[1] 黄妩姣, 郑智明, 林素香,等. CEA和CA724联合检测在结直肠癌诊断中的应用[J]. 实用医学杂志, 2011, 27(12):2252-2254. [2] Bhaskar A,Cupta B,Sreenivas V,et al.Synergistic effect of vascular endothelial growth factor and angiopoietin -2 on progression free survival in multiple myeloma[J].Leuk Res,2013,37(4):410-415. [3] Lee SE,Lee JH,Ryu KW,et al.Preoperative plasma fibrinogen level is a useful predictor of adjacent organ involvement in patients with advanced gastric cancer[J].J Gastric Cancer,2012,12(2):81-87. [4] Daly C, Eichten A, Castanaro C, et al. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGFinhibition[J]. Cancer Res, 2013, 73(1):108-118. [5] Diaz-Sanchez A, Matilla A, Nuez O, et al. Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma[J]. Scand J Gastroenterol, 2013, 48(3):334-343. [6] Goede V, Coutelle O, Neuneier J, et al. Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy[J]. Br J Cancer, 2010, 103(103):1407-1414. [7] Mazzieri R, Pucci F, Moi D, et al. Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells[J]. Cancer Cell, 2011, 19(4):512-526. [8] Halkia E, Kalinoglou N. Challenges with identification of angiogenesis biomarkers in cancer[J]. Surg Endosc, 2011, 25(8):2769-2770. [9] Holopainen T, Saharinen P, D’Amico G, et al. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis[J]. J Natl Cancer Inst, 2012, 104(6):461-475. [10] 龙璐,陶亚,王埅,等.同型半胱氨酸,超敏C反应蛋白及纤维蛋白原检测对急性脑梗死患者的临床意义[J].实用预防医学,2013,20(5):599-601. [11] Falangs A,Russo L,Verzeroli C.Mechanisms of thrombosis in cancer[J].Thromb Res,2013,131(Suppl 1):S59-62.